Predict your next investment

Venture Capital
acerasbio.com

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Aceras BioMedical

Aceras BioMedical is a healthcare investment firm focused on emerging development stage private and public biotechnology and medical device companies. Specializing in the licensing/acquisition and internal development of therapeutic products/medical devices through the formation of new companies.

Aceras BioMedical Headquarter Location

New York, New York, 10020,

United States

(212)-430-1798

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aceras BioMedical Investments

1 Investments

Aceras BioMedical has made 1 investments. Their latest investment was in Modis Therapeutics as part of their Series A on October 10, 2018.

CBI Logo

Aceras BioMedical Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/1/2018

Series A

Modis Therapeutics

$30M

Yes

1

Date

10/1/2018

Round

Series A

Company

Modis Therapeutics

Amount

$30M

New?

Yes

Co-Investors

Sources

1

Aceras BioMedical Portfolio Exits

1 Portfolio Exit

Aceras BioMedical has 1 portfolio exit. Their latest portfolio exit was Modis Therapeutics on August 26, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/26/2019

Acquired

$991

3

Date

8/26/2019

Exit

Acquired

Companies

Valuation

$991

Acquirer

Sources

3

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.